Study: Unattractive people far overestimate their looks

The finding is remarkably similar to the Dunning-Kruger effect, which describes how incompetent people tend to overestimate their own competency.

smiling man
  • Recent studies asked participants to rate the attractiveness of themselves and other participants, who were strangers.
  • The studies kept yielding the same finding: unattractive people overestimate their attractiveness, while attractive people underrate their looks.
  • Why this happens is unclear, but it doesn't seem to be due to a general inability to judge attractiveness.

There's no shortage of disparities between attractive and unattractive people. Studies show that the best-looking among us tend to have an easier time making money, receiving help, avoiding punishment, and being perceived as competent. (Sure, research also suggests beautiful people have shorter relationships, but they also have more sexual partners, and more options for romantic relationships. So call it a wash.)

Now, new research reveals another disparity: Unattractive people seem less able to accurately judge their own attractiveness, and they tend to overestimate their looks. In contrast, beautiful people tend to rate themselves more accurately. If anything, they underestimate their attractiveness.

The research, published in the Scandinavian Journal of Psychology, involved six studies that asked participants to rate the attractiveness of themselves and other participants, who were strangers. The studies also asked participants to predict how others might rate them.

In the first study, lead author Tobias Greitemeyer found that the participants who were most likely to overestimate their attractiveness were among the least attractive people in the study, based on average ratings.

Ratings of subjective attractiveness as a function of the participant's objective attractiveness (Study 1)

Greitemeyer

"Overall, unattractive participants judged themselves to be of about average attractiveness and they showed very little awareness that strangers do not share this view. In contrast, attractive participants had more insights into how attractive they actually are. [...] It thus appears that unattractive people maintain illusory self‐perceptions of their attractiveness, whereas attractive people's self‐views are more grounded in reality."

Why do unattractive people overestimate their attractiveness? Could it be because they want to maintain a positive self-image, so they delude themselves? After all, previous research has shown that people tend to discredit or "forget" negative social feedback, which seems to help protect a sense of self-worth.

NBC

To find out, Greitemeyer conducted a study that aimed to put participants in a positive, non-defensive mindset before rating attractiveness. He did that by asking participants questions that affirmed parts of their personality that had nothing to do with physical appearance, such as: "Have you ever been generous and selfless to another person?" Yet, this didn't change how participants rated themselves, suggesting that unattractive people aren't overestimating their looks out of defensiveness.

The studies kept yielding the same finding: unattractive people overestimate their attractiveness. Does that bias sound familiar? If so, you might be thinking of the Dunning-Kruger effect, which describes how incompetent people tend to overestimate their own competency. Why? Because they lack the metacognitive skills needed to discern their own shortcomings.

Greitemeyer found that unattractive people were worse at differentiating between attractive and unattractive people. But the finding that unattractive people may have different beauty ideals (or, more plainly, weaker ability to judge attractiveness) did "not have an impact on how they perceive themselves."

In short, it remains a mystery exactly why unattractive people overestimate their looks. Greitemeyer concluded that, while most people are decent at judging the attractiveness of others, "it appears that those who are unattractive do not know that they are unattractive."

Unattractive people aren't completely unaware

The results of one study suggested that unattractive people aren't completely in the dark about their looks. In the study, unattractive people were shown a set of photos of highly attractive and unattractive people, and they were asked to select photos of people with comparable attractiveness. Most unattractive people chose to compare themselves with similarly unattractive people.

"The finding that unattractive participants selected unattractive stimulus persons with whom they would compare their attractiveness to suggests that they may have an inkling that they are less attractive than they want it to be," Greitemeyer wrote.

U.S. Navy controls inventions that claim to change "fabric of reality"

Inventions with revolutionary potential made by a mysterious aerospace engineer for the U.S. Navy come to light.

U.S. Navy ships

Credit: Getty Images
Surprising Science
  • U.S. Navy holds patents for enigmatic inventions by aerospace engineer Dr. Salvatore Pais.
  • Pais came up with technology that can "engineer" reality, devising an ultrafast craft, a fusion reactor, and more.
  • While mostly theoretical at this point, the inventions could transform energy, space, and military sectors.
Keep reading Show less

Why so gassy? Mysterious methane detected on Saturn’s moon

Scientists do not know what is causing the overabundance of the gas.

An impression of NASA's Cassini spacecraft flying through a water plume on the surface of Saturn's moon Enceladus.

Credit: NASA
Surprising Science
  • A new study looked to understand the source of methane on Saturn's moon Enceladus.
  • The scientists used computer models with data from the Cassini spacecraft.
  • The explanation could lie in alien organisms or non-biological processes.
Keep reading Show less

CRISPR therapy cures first genetic disorder inside the body

It marks a breakthrough in using gene editing to treat diseases.

Credit: National Cancer Institute via Unsplash
Technology & Innovation

This article was originally published by our sister site, Freethink.

For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

We can overcome one of the biggest challenges with applying CRISPR clinically.

—JENNIFER DOUDNA

"This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

"While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

This is a wonderful day for the future of gene-editing as a medicine.

—FYODOR URNOV

If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

"This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."

Quantcast